4.6 Review

SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets?

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 27, Issue 9, Pages 653-664

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2016.03.011

Keywords

-

Funding

  1. National Institutes of Health [R01DK104927-01A1]
  2. University of Chicago DRTC [P30DK020595]
  3. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development [1IK2BX001587-01]
  4. American Heart Association [15POST22410016]
  5. Chicago Biomedical Consortium
  6. Searle Funds at the Chicago Community Trust

Ask authors/readers for more resources

Nutrient sensing receptors are key metabolic mediators of responses to dietary and endogenously derived nutrients. These receptors are largely G-protein coupled receptors (GPCRs) and many are gaining significant interest as drug targets with a potential therapeutic role in metabolic diseases. A distinct subclass of nutrient sensing GPCRs, two short chain fatty acid (SCFA) receptors (FFA2 and FFA3) are uniquely responsive to gut microbiota derived nutrients (such as acetate, propionate, and butyrate). Pharmacological, molecular, and genetic studies have investigated their role in organismal glucose metabolism and recently in pancreatic beta cell biology. Here, we summarize the present knowledge on the role of these receptors as metabolic sensors in beta cell function and physiology, revealing new therapeutic opportunities for type 2 diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available